Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.05/sh

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.05). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.07 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• RedHill Biopharma closes $6M private placement with warrant upside